Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. (2018)
Attributed to:
The University of Manchester (UoM) bid for phase 4 of MRC Confidence in Concept (CiC) funding
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/brain/awx311
PubMed Identifier: 29186350
Publication URI: http://europepmc.org/abstract/MED/29186350
Type: Journal Article/Review
Volume: 141
Parent Publication: Brain : a journal of neurology
Issue: 1
ISSN: 0006-8950